This article has Open Peer Review reports available.
Comparison of vilanterol, a novel long-acting beta2 agonist, with placebo and a salmeterol reference arm in asthma uncontrolled by inhaled corticosteroids
© Lötvall et al.; licensee BioMed Central Ltd. 2014
Received: 19 June 2013
Accepted: 14 May 2014
Published: 13 June 2014
Open Peer Review reports
Pre-publication versions of this article and author comments to reviewers are available by contacting email@example.com.
|19 Jun 2013||Submitted||Original manuscript|
|2 Dec 2013||Reviewed||Reviewer Report - David Price|
|8 Dec 2013||Reviewed||Reviewer Report - Leif Bjermer|
|24 Apr 2014||Author responded||Author comments - Jan Lotvall|
|Resubmission - Version 2|
|24 Apr 2014||Submitted||Manuscript version 2|
|13 May 2014||Author responded||Author comments - Jan Lotvall|
|Resubmission - Version 3|
|13 May 2014||Submitted||Manuscript version 3|
|14 May 2014||Editorially accepted|
|13 Jun 2014||Article published||10.1186/1477-5751-13-9|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting firstname.lastname@example.org. All previous versions of the manuscript and all author responses to the reviewers are also available.
You can find further information about the peer review system here.